000250.KQ
Sam Chun Dang Pharm. Co., Ltd
KOE · Healthcare · Medical - Pharmaceuticals · KR
KRW 155,400.00
−2.26%Year over year
Reported trailing growth
- Revenue
- +20.8%
- EBITDA
- -20.4%
- EBIT
- +1105.4%
- EPS
- +217.1%
- Free cash flow
- +11.9%
- Operating cash flow
- +711.6%
Forward estimates
Based on analyst estimates
- Revenue
- -34.5%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +9.3%
- EBITDA
- -0.1%
- EBIT
- -12.8%
- Net income
- -3.4%
- EPS
- -5.1%
- Free cash flow
- -86.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026